Volume 122, Issue 1 , Pages 166-172.e2, July 2008
Antiretroviral therapy corrects HIV-1–induced expansion of CD8+CD45RA+CD27−CD11abright activated T cells
Background
HIV infection decreases thymic output and induces chronic T-cell activation.
Objective
To examine the reconstitution of naive and activated T cells.
Methods
Extended immune phenotyping of CD4+ and CD8+ T-cell subsets was combined with T-cell receptor rearrangement excision circle (TREC) levels and measures of T-cell receptor repertoire perturbations in CD8+ T-cell subpopulation to define the global effect of HIV-1 on T-cell dynamics. Evaluations before and after therapy were performed in HIV-infected children and compared with those in healthy individuals.
Results
Ten HIV-infected children and adolescents with a broad range of pretherapy CD4+ T-cell counts were compared with healthy individuals. Pretherapy late activated CD8+ T cells (CD3+CD8+CD45RA+CD27−CD11abright cells) were expanded among HIV-infected subjects. Successful antiretroviral therapy increased the proportion of naive T cells (CD3+CD4+CD45RA+CD27+CD28+ and CD3+CD8+CD45RA+CD27+CD11adim cells), with a significant decrease in late activated CD8+ T cells. The proportion of naive CD4+ and CD8+ T cells significantly predicted log10 TREC copies/106 PBMCs in infected children and healthy control subjects, with a negative correlation in late activated CD8+ T cells and activated CD4+ T cells. Treatment re-established Gaussian distributions and decreased oligoclonal expansion within the Vβ repertoire of CD8+CD45RA+ T cells, but compared with that seen in healthy children, the proportion of late activated CD8+ T cells remained increased.
Conclusion
HIV infection strikingly shifts the proportion of naive and late activated CD45RA+CD8+ T cells. Homeostasis within this T-cell population reflects TREC levels and the extent of T-cell receptor Vβ perturbations.
Key words: HIV-1, children, T-cell receptor, T-cell receptor rearrangement excision circles, immune reconstitution, flow cytometry, T cells
Abbreviations used: TCR, T-cell receptor, TREC, T-cell receptor rearrangement excision circle
Supported by Public Health Service R01 awards HD032259, AI065265, AI028571, and AI047723; the Pediatric Clinical Research Center of All Children's Hospital and the University of South Florida, Maternal Child Health Bureau, R60 MC 00003-01, Department of Health and Human Services, Resources and Services Administration, University of Florida Center for Research for Pediatric Immune Deficiency; and the Stephany W. Holloway University Chair for AIDS Research (M.M.G.).
Disclosure of potential conflict of interest: C. A. Rodriguez and M. M. Goodenow have received research support from the National Institutes of Health (NIH). J. W. Sleasman has consulting arrangements with CSL Behring and has received research support from the NIH, the Florida Department of Health, the National Oceanic Atmospheric Administration, the Florida Fish and Wildlife Conservation Commission, and CSL Behring. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)00773-2
doi:10.1016/j.jaci.2008.04.029
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 122, Issue 1 , Pages 166-172.e2, July 2008
